(19)
(11) EP 1 414 806 A1

(12)

(43) Date of publication:
06.05.2004 Bulletin 2004/19

(21) Application number: 02745184.8

(22) Date of filing: 05.07.2002
(51) International Patent Classification (IPC)7C07D 235/16, C07D 279/22, C07D 471/04, C07D 209/86, C07D 223/22, A61K 31/538, A61K 31/5415, A61K 31/403, A61K 31/55, A61P 1/18, A61P 3/06, A61P 3/10
(86) International application number:
PCT/DK2002/000469
(87) International publication number:
WO 2003/011834 (13.02.2003 Gazette 2003/07)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 30.07.2001 DK 200101156

(71) Applicant: NOVO NORDISK A/S
2880 Bagsvaerd (DK)

(72) Inventors:
  • JEPPESEN, Lone
    DK-2830 Farum (DK)
  • BURY, Paul, Stanley
    Burnely, Lancashire BB11 4PA (GB)
  • MOGENSEN, John, Patrick
    DK-2730 Herlev (DK)
  • PETTERSSON, Ingrid
    DK-1864 Frederiksberg (DK)
  • SAUERBERG, Per
    DK-3520 Farum (DK)

(74) Representative: Madsen, Inger Margrethe Schelde et al
c/o Novo Nordisk A/S,Patent Department,Novo Allé
2880 Bagsvaerd
2880 Bagsvaerd (DK)

   


(54) NOVEL VINYL N-(2-BENZOYLPHENYL)-L-TYROSINE DERIVATIVES AND THEIR USE AS ANTIDIABETICS ETC